Skip to search formSkip to main contentSkip to account menu

docarpamine

Known as: N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine, do carpamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Ascites is the most common complication of liver cirrhosis, and it develops as a consequence of portal hypertension and… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND Salt-sensitive (SS) hypertension affects >30 million Americans and is often associated with low plasma renin activity… 
2003
2003
Dopamine treatment constitutes a major advance towards the management of severe ovarian hyperstimulation syndrome (OHSS) by… 
Review
2002
Review
2002
  • S. Doggrell
  • Expert opinion on investigational drugs
  • 2002
  • Corpus ID: 29186197
In the periphery, physiological dopamine increases renal blood flow, decreases renal resistance and acts on the kidney tubule to… 
2000
2000
We studied the effects of bolus intravenous injection of the dopamine prodrug, docarpamine (200 μg/kg), on mean arterial pressure… 
Review
1999
Review
1999
BACKGROUND Docarpamine (DOC) is a dopamine prodrug which can be orally administered. It has been found that oral docarpamine… 
1999
1999
OBJECTIVE:Refractory ascites is a debilitating condition in patients with cirrhosis. Recently, docarpamine, an orally active… 
1995
1995
Docarpamine is a dopamine prodrug which has been selected from a large number of dopamine derivatives in order to develop an… 
1991
1991
Positive inotropic and renal vasodilatory effects of a novel dopamine prodrug, docarpamine, [N-(N-acetyl-L-methionyl)-3,4-bis… 
1990
1990
The metabolism of an orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and of…